CD8A and neoplasm: Tumor cells secrete PD-L1 via exosomes (exoPD-L1), which binds to PD-1 on CD8+ T cells at metastatic sites, inhibiting T cell activation and proliferation, leading to their functional inactivation and immunosuppression (112–115).